Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen

MLA

Yixiang Zhan, et al. “Stage III Deficient Mismatch Repair Colon Patients Get Greater Benefit from Earlier Starting Oxaliplatin-Based Chemotherapy Regimen.” Scientific Reports, vol. 13, no. 1, June 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1038/s41598-023-33153-8.

APA

Yixiang Zhan, Kemin Ni, Zhaoce Liu, Ran xin, Qiurong Han, Hangyu Ping, Yaohong Liu, Xuanzhu Zhao, Wanting Wang, Suying Yan, Jing Sun, Qinghuai Zhang, Guihua Wang, Zili Zhang, Xipeng Zhang, Xia Hu, Guoxun Li, & Chunze Zhang. (2023). Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen. Scientific Reports, 13(1), 1–8. https://doi.org/10.1038/s41598-023-33153-8

Chicago

Yixiang Zhan, Kemin Ni, Zhaoce Liu, Ran xin, Qiurong Han, Hangyu Ping, Yaohong Liu, et al. 2023. “Stage III Deficient Mismatch Repair Colon Patients Get Greater Benefit from Earlier Starting Oxaliplatin-Based Chemotherapy Regimen.” Scientific Reports 13 (1): 1–8. doi:10.1038/s41598-023-33153-8.